Pitt: A shot of young stem cells made rapidly aging mice live longer and healthier Read more

British scientists have made the first human embryonic stem cells of a high enough grade to use in patients and deposited them in a public stem-cell bank for development in human trials by drug com... Read more

Dr. Michael Rudnicki in his regenerative medicine lab at the Ottawa Hospital resrach Institute's Sprott Centr for Stem Cll Research Read more

Researchers have been able to genetically create a strain of “mighty mice” that are twice as strong as normal mice, raising treatment hopes for a range of illnesses involving muscle degeneration. Read more

A 'molecular scalpel' shows promise in patients with a deadly muscle wasting condition, according to researchers. Read more

Research part-funded by the Muscular Dystrophy Campaign by Professor George Dickson at Royal Holloway University of London has shown in mice that long term administration of the exon skipping drug ... Read more

Researchers have long known that the devastating disease called Duchenne muscular dystrophy (DMD) is caused by a single mutation in a gene called dystrophin. The protein encoded by that gene is ... Read more

Children with Duchenne muscular dystrophy (DMD) face a future of rapidly weakening ... Research in MU's Department of Molecular Microbiology and Immunology. ... Read more

We are very excited to be offering a clinical trial to this older Duchenne muscular dystrophy population with this promising drug, said Dr. Kathryn Wagner, Director of the Center for Genetic Muscle... Read more

Newswise — An immune reaction to dystrophin, the muscle protein that is defective in patients with Duchenne muscular dystrophy, may pose a new challenge to strengthening muscles of patients with th... Read more

Now, geneticists have discovered ways in which to skip over the faulty genetic code that causes MD, in order to halt the progression of the disease. This is called exon skipping. Read more

Quebec City, April 15, 2010–Researchers from Université Laval's Faculty of Medicine and the CHUQ Research Center have proven that it is possible to repair the defective gene responsible for Duchen... Read more

Jesse’s Journey is today announcing it is providing Duchenne researchers with more than $500,000 in new research funding for 2010, in addition to the $500,000 in grants made this year, for a two ye... Read more

Treat NMD 2010 Bringing down the barriers Read more